021-51111890
购物车（）
sales@molnova.cn
Ranibizumab
CAS No. 347396-82-1
Ranibizumab ( —— )
产品货号. M22159 CAS No. 347396-82-1
Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥6990 | 有现货 |
|
| 10MG | ￥11178 | 有现货 |
|
| 25MG | ￥16038 | 有现货 |
|
| 50MG | ￥22437 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ranibizumab
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A.
-
产品描述Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A.
-
同义词——
-
通路Angiogenesis
-
靶点VEGFR
-
受体VEGFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number347396-82-1
-
分子量48 kDa
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Klettner A, et al.Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4523-7.
产品手册
关联产品
-
SU14813 maleate
A broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
-
Pazopanib
A potent, orally available, pan-VEGFR inhibitor with IC50 of 10, 30, and 47 nM for VEGFR-1, -2, and -3, respectively.
-
Fruquintinib
A potent and highly selective small molecule inhibitor of VEGFR1/2/3 with IC50 of 33/3/5/0.5 nM, respectively.
